United States · Series C startup

Who invested in Dermira

6 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$169Mraised across 6 rounds since 2011, from 6 sources

$42MSeries A$3.3MVenture$34MSeries C$4.0MVenture$35MSeries B$51MSeries C
Latest round
Series C, $51MAug 2014
Step-upi
1.5×
Investors
9
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201220132014
$42MSeries A$3.3MVenture$34MSeries C$4.0MVenture$35MSeries B$51MSeries C
First round
Series A, $42M
Oct 2011
Biggest round
$51M
Series C · Aug 2014
Usual gap between rounds
7 months
the median of 5

The rounds

  1. Aug 2014
    Series C$51M5 new3 returning

    From a historical funding recordSEC filing: $51M sold, first sale Aug 2014

  2. Jun 2013
    Series B$35M1 new3 returning

    Reported by businesswire.comSEC filing: $25M sold, first sale Mar 2013

  3. Apr 2013
    Venture$4.0M1 returning

    From a historical funding recordSEC filing: $25M sold, first sale Mar 2013

  4. Sept 2012
    Series C$34M

    No investor was named in the report.

    Reported by sec.govSEC filing: $34M sold, first sale Aug 2011

  5. Jul 2012
    Venture$3.3M1 returning

    From a historical funding recordSEC filing: $34M sold, first sale Aug 2011

  6. Oct 2011

Founders and team

From the SEC filings it signed: 7 on the team.

  • Andrew L. GuggenhimeExecutive Officeri
  • Christopher M. GriffithExecutive Officeri
  • Christopher R. HoranExecutive Officeri
  • Eugene A. BauerExecutive Officer, Directori
  • Lori L. Lyons-WilliamsExecutive Officeri
  • Luis C. PenaExecutive Officeri
  • Thomas G. WiggansExecutive Officer, Directori

On the board, as filediDavid E. CohenFred B. CravesJake R. NunnKathleen R. SebeliusMark D. McDadeMatthew K. FustWilliam R. Ringo

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

CanaanVC firm5rounds
Bay City CapitalVC firm3rounds
Aisling CapitalPrivate equity1round
Rock Springs CapitalHedge fund1round
Apple Tree PartnersVC firm1round
Sabby CapitalPrivate equity1round
UCB PharmaVC firm1round
MaruhoCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Dermira as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Athyrium Capital ManagementPrivate equityPer its own site

Quick answers about Dermira

Who invested in Dermira?

Dermira's investors include Canaan, New Enterprise Associates, Bay City Capital, Aisling Capital and Rock Springs Capital, and 4 more on record.

How much has Dermira raised?

Dermira has raised $169M across 6 rounds since 2011.

When did Dermira last raise?

Dermira's most recent round was a Series C of $51M in Aug 2014.

What was Dermira's biggest round?

Its most recent round, $51M in Aug 2014, is also its largest on record.

Who backed Dermira first?

Dermira's first round on record, in Oct 2011, was backed by New Enterprise Associates, Canaan and Bay City Capital.

What stage is Dermira at?

Dermira's latest named round is a Series C, in Aug 2014.

Where is Dermira based?

Dermira is based in the United States.

Companies like Dermira

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.